Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 38 results.
User Information
Export Records
  1. 1.   Application of Post Solid-Phase Oxime Ligation to Fine-Tune Peptide-Protein Interactions
  2. Zhao,Xue Zhi; Liu, Fa; Burke,Terrence
  3. Molecules (Basel, Switzerland). 2020, JUN; 25(12):
  1. 2.   LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studies
  2. O'Neill,Maura; Chan,King; Jaynes, Jesse M; Knotts, Zachary; Xu,Xia; Abisoye-Ogunniyan, Abisola; Guerin,Theresa; Schlomer,Jerome; Li, Dandan; Cary, Jeffrey W; Rajasekaran, Kanniah; Yates, Clayton; Kozlov,Serguei; Andresson,Thorkell; Rudloff, Udo
  3. Journal of pharmaceutical and biomedical analysis. 2020, Mar 20; 181: 113093.
  1. 3.   NCI Program for Natural Product Discovery: A Publicly-Accessible Library of Natural Product Fractions for High-Throughput Screening
  2. Thornburg,Chris; Britt,John; Evans,Jason; Akee,Rhone; Whitt, James A.; Trinh,Spencer; Harris,Matthew; Thompson,Jerell; Ewing,Teresa; Shipley,Suzanne; Grothaus,Paul; Newman,Dave; Schneider,Joel; Grkovic,Tanja; O'Keefe,Barry
  3. ACS CHEMICAL BIOLOGY. 2018, Sep 21; 13(9): 2484-2497.
  1. 4.   Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors
  2. Bahta, M.; Liu, F.; Kim, S. E.; Stephen, A. G.; Fisher, R. J.; Burke, T. R.
  3. Nature Protocols. 2012, Apr; 7(4): 686-702.
  1. 5.   Inhibition of multi-drug resistant HIV-1 reverse transcriptase by nucleoside beta-triphosphates
  2. Dash, C.; Ahmadibeni, Y.; Hanley, M. J.; Pandhare, J.; Gotte, M.; Le Grice, S. F. J.; Parang, K.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Jun; 21(12): 3519-3522.
  1. 6.   Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists
  2. Liu, F.; Stephen, A. G.; Waheed, A. A.; Freed, E. O.; Fisher, R. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2010, Jan; 20(1): 318-321.
  1. 7.   Application of a trifunctional reactive linker for the construction of antibody-drug hybrid conjugates
  2. Thomas, J. D.; Hofer, T.; Rader, C.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2008 18(21): 5785-5788.
  1. 9.   Biotinylated biphenyl ketone-containing 2,4-dioxobutanoic acids designed as HIV-1 integrase photoaffinity ligands
  2. Zhao, X. Z.; Semenova, E. A.; Liao, C. Z.; Nicklaus, M.; Pommier, Y.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry. 2006, Dec; 14(23): 7816-7825.
  1. 10.   Hydrazone- and hydrazide-containing N-substituted glycines as peptoid surrogates for expedited library synthesis: Application to the preparation of Tsg101-directed HIV-1 budding antagonists
  2. Liu, F.; Stephen, A. G.; Adamson, C. S.; Gousset, K.; Aman, M. J.; Freed, E. O.; Fisher, R. J.; Burke, T. R.
  3. Organic Letters. 2006, Oct; 8(22): 5165-5168.
  1. 11.   Determination of paclitaxel in human plasma following the administration of Genaxol or Genetaxyl by liquid chromatography/tandem mass spectrometry
  2. Gardner, E. R.; Liau, C. T.; Chu, Z. T. E.; Figg, W. D.; Sparreboom, A.
  3. Rapid Communications in Mass Spectrometry. 2006 20(14): 2170-2174.
  1. 12.   Design and synthesis of phosphonodifluoromethyl phenylalanine (F(2)Pmp): A useful phosphotyrosyl mimetic
  2. Burke, T. R.
  3. Current Topics in Medicinal Chemistry. 2006 6(14): 1465-1471.
  1. 13.   International collaboration in drug discovery and development from natural sources
  2. Cragg, G. M.; Newman, D. J.
  3. Pure and Applied Chemistry. 2005, NOV; 77(11): 1923-1942.
  1. 14.   Analysis of albumin-associated peptides and proteins from ovarian cancer patients
  2. Lowenthal, M. S.; Mehta, A. I.; Frogale, K.; Bandle, R. W.; Araujo, R. P.; Hood, B. L.; Veenstra, T. D.; Conrads, T. P.; Goldsmith, P.; Fishman, D.; Petricoin, E. F.; Liotta, L. A
  3. Clinical Chemistry. 2005, OCT; 51(10): 1933-1945.
  1. 15.   Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4
  2. Yang, Q. E.; Stephen, A. G.; Adelsberger, J. W.; Roberts, P. E.; Zhu, W. M.; Currens, M. J.; Feng, Y. X.; Crise, B. J.; Gorelick, R. J.; Rein, A. R.; Fisher, R. J.; Shoemaker, R. H.; Sei, S.
  3. Journal of Virology. 2005, MAY; 79(10): 6122-6133.
  1. 16.   The search for novel drug leads for predominately antitumor therapies by utilizing mother nature's pharmacophoric libraries
  2. Kingston, D. G. I.; Newman, D. J.
  3. Current Opinion in Drug Discovery & Development. 2005, MAR; 8(2): 207-227.
  1. 17.   Synthesis of gold nanoparticles bearing the Thomsen-Friedenreich disaccharide: a new multivalent presentation of an important tumor antigen
  2. Svarovsky, S. A.; Szekely, Z.; Barchi, J. J.
  3. Tetrahedron-Asymmetry. 2005, JAN 24; 16(2): 587-598.
  1. 18.   Synthesis of trishomocubane amino acid derivatives
  2. Govender, T.; Hariprakasha, H. K.; Kruger, H. G.; Raasch, T.
  3. South African Journal of Chemistry-Suid-Afrikaanse Tydskrif Vir Chemie. 2005 58: 37-40.
  1. 19.   The discovery of protein kinase C (PK-C) isozyme: Specific ligands driven by a solid-phase combinatorial synthesis of diacylglycerol-lactones (DAG-lactones)
  2. Duan, D. H.; Peach, M. L.; Lai, C. C.; Lewin, N. E.; Kelley, J. A.; Blumberg, P. M.; Marquez, V. E.
  3. Abstracts of Papers of the American Chemical Society. 2004, AUG 22; 228(Part 1): 177-MEDI, Abstract U939-177-MEDI, Abstract U939.
  1. 20.   Enantioselective synthesis of metathesis-derived ureapeptoid macrocycles
  2. Wang, X. Z.; Burke, T. R.
  3. Synlett. 2004 (3): 469-472.
  1. 22.   Development of L-3-aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding affinity
  2. Song, Y. L.; Roller, P. P.; Long, Y. Q.
  3. Bioorganic & Medicinal Chemistry Letters. 2004 14(12): 3205-3208.
  1. 23.   Enantioselective synthesis of (S)-3-carboxy-4-((carboxy)difluoromethyl)phenylalanine in protected form and its incorporation into a PTP-1B-directed tripeptide
  2. Kang, S. U.; Yang, G.; Li, W.; Zhang, Z. Y.; Burke, T. R.
  3. Chemistry & Biodiversity. 2004 1(4): 626-633.
  1. 24.   Synthesis, stability, and protonation studies of a self- complementary dodecamer containing the modified nucleoside 2 '- deoxyzebularine
  2. Vives, M.; Eritja, R.; Tauler, R.; Marquez, V. E.; Gargallo, R.
  3. Biopolymers. 2004 73(1): 27-43.
  1. 25.   Conceptual "heat-driven" approach to the synthesis of DNA oligonucleotides on microarrays
  2. Grajkowski, A.; Cieslak, J.; Chmielewski, M. K.; Marchan, V.; Phillips, L. R.; Wilk, A.; Beaucage, S. L.
  3. THERAPEUTIC OLIGONUCLEOTIDES. 2003; 1002 : 1-11.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel